A 65-year-old woman presenting with cardiac sarcoidosis underwent serial measurement of her serum high-sensitivity cardiac troponin I (Hs-cTnI) and N-terminal proB-type natriuretic peptide (NT-proBNP) concentrations. She was treated with 1,000 mg/day methylprednisolone for 2 days, which was subsequently replaced by 30 mg/day prednisolone, and decreased to 20 mg/day at the time of discharge, 2 months later. Her echocardiogram showed improvements in the left ventricular systolic and diastolic function, along with a decrease in the concentration of Hs-cTnI and NT-proBNP. This is the first report suggesting that Hs-cTnI might be a reliable means of assessing the effects of treatment of cardiac sarcoidosis. © 2012, The Japanese Society of Internal Medicine. All rights reserved.
CITATION STYLE
Tanada, Y., Sato, Y., Sawa, T., Fujiwara, H., & Takatsu, Y. (2012). Serial Measurement of High-Sensitivity Cardiac Troponin I and N-Terminal proB-Type Natriuretic Peptide in a Patient Presenting with Cardiac Sarcoidosis. Internal Medicine, 51(24), 3379–3381. https://doi.org/10.2169/internalmedicine.51.8334
Mendeley helps you to discover research relevant for your work.